Top News: #Cancer

Here are the top read news for #cancer:


 

461439230 A HTH USA NYJimmy Carter’s remission shows power of new cancer drugs:

Carter, 91, announced his cancer was in remission at the Sunday school class he regularly teaches at a church in Plains, Ga. According to the Carter Center, his most recent brain scan “did not reveal any signs of the original cancer spots nor any new ones.”  He has not said that he is cured, and experts say his cancer could still come back. Read more


 

Cancer cells.J&J leukemia drug cuts death risk vs. chemo in new patients, study finds:

Johnson & Johnson’s and AbbVie’s cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. Read more


 

New Vaccine Strategy Better Protects High-Risk Cancer Patients From Flu:

Patients with cancers of the immune system, like multiple myeloma, are especially susceptible to common infections, and a bout of the flu can lead to serious illness and even death. Even though patients with multiple myeloma and other plasma cell disorders may receive an annual flu vaccine, studies show that a one-time flu shot does not offer adequate immune response. Read more


 

[Person undergoing chemotherapy]Which chemotherapy drug causes the worst ‘chemobrain’?:

Patients who undergo chemotherapy for breast cancer often report a long-lasting drop in cognitive functioning. New research investigates which drug causes the worst cognitive deficits. Read more 


 

The new frontiers in cancer research were discussed at the Forbes Healthcare Summit. (Glen Davis)Harnessing The Immune System To Fight Cancer: ‘Now We Can Offer Hope’:

In the quest for a cancer cure, 2015 may well be remembered as the renaissance of immunotherapy. For most of the last century, cancer researchers have been trying to harness the immune system to kill cancer, with limited success—until recently. Read more


 

 

Advertisements